Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreas, Artificial | 23 | 2023 | 28 | 10.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 33 | 2024 | 566 | 9.540 |
Why?
|
| Blood Glucose | 32 | 2023 | 837 | 6.860 |
Why?
|
| Hypoglycemic Agents | 20 | 2024 | 352 | 4.840 |
Why?
|
| Insulin | 25 | 2024 | 1148 | 4.840 |
Why?
|
| Insulin Infusion Systems | 18 | 2024 | 37 | 3.530 |
Why?
|
| Blood Glucose Self-Monitoring | 14 | 2022 | 54 | 3.310 |
Why?
|
| Exercise | 14 | 2023 | 328 | 3.310 |
Why?
|
| Algorithms | 24 | 2024 | 1912 | 2.500 |
Why?
|
| Meals | 7 | 2022 | 22 | 2.250 |
Why?
|
| Hypoglycemia | 11 | 2019 | 107 | 2.160 |
Why?
|
| Signal Processing, Computer-Assisted | 7 | 2017 | 202 | 1.820 |
Why?
|
| Models, Biological | 8 | 2024 | 1766 | 1.640 |
Why?
|
| Neovascularization, Physiologic | 6 | 2020 | 143 | 1.410 |
Why?
|
| Wearable Electronic Devices | 3 | 2020 | 27 | 1.410 |
Why?
|
| Biocompatible Materials | 5 | 2015 | 198 | 1.330 |
Why?
|
| Tissue Scaffolds | 7 | 2020 | 116 | 1.300 |
Why?
|
| Hyperglycemia | 5 | 2017 | 172 | 1.120 |
Why?
|
| Monitoring, Physiologic | 4 | 2019 | 266 | 1.050 |
Why?
|
| Computer Simulation | 9 | 2024 | 1102 | 0.960 |
Why?
|
| Glucosides | 1 | 2024 | 13 | 0.940 |
Why?
|
| Benzhydryl Compounds | 1 | 2024 | 44 | 0.930 |
Why?
|
| Clinical Alarms | 4 | 2016 | 16 | 0.880 |
Why?
|
| Glomerular Filtration Rate | 1 | 2024 | 278 | 0.850 |
Why?
|
| Models, Theoretical | 5 | 2019 | 493 | 0.840 |
Why?
|
| Equipment Failure Analysis | 3 | 2016 | 91 | 0.830 |
Why?
|
| Metformin | 1 | 2024 | 124 | 0.830 |
Why?
|
| Dietary Carbohydrates | 3 | 2017 | 39 | 0.800 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 222 | 0.750 |
Why?
|
| Multivariate Analysis | 6 | 2017 | 983 | 0.640 |
Why?
|
| Humans | 43 | 2024 | 90071 | 0.640 |
Why?
|
| Tissue Engineering | 4 | 2020 | 191 | 0.570 |
Why?
|
| Machine Learning | 2 | 2024 | 270 | 0.560 |
Why?
|
| Models, Statistical | 4 | 2019 | 576 | 0.540 |
Why?
|
| Motor Activity | 2 | 2015 | 327 | 0.530 |
Why?
|
| Models, Cardiovascular | 2 | 2015 | 107 | 0.530 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 1735 | 0.530 |
Why?
|
| Artificial Intelligence | 3 | 2024 | 332 | 0.500 |
Why?
|
| Absorbable Implants | 1 | 2015 | 35 | 0.500 |
Why?
|
| Blood Vessels | 1 | 2015 | 94 | 0.500 |
Why?
|
| Young Adult | 10 | 2021 | 6424 | 0.470 |
Why?
|
| Islets of Langerhans | 1 | 2018 | 549 | 0.460 |
Why?
|
| Adolescent | 9 | 2021 | 9363 | 0.460 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 20 | 0.450 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 600 | 0.440 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 178 | 0.440 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 244 | 0.430 |
Why?
|
| Hydrogels | 3 | 2019 | 87 | 0.400 |
Why?
|
| Porosity | 5 | 2015 | 61 | 0.390 |
Why?
|
| Adult | 13 | 2021 | 26855 | 0.380 |
Why?
|
| Computer Systems | 2 | 2016 | 79 | 0.350 |
Why?
|
| Equipment Design | 4 | 2015 | 422 | 0.350 |
Why?
|
| Male | 15 | 2024 | 42741 | 0.340 |
Why?
|
| Polyethylene Glycols | 2 | 2015 | 360 | 0.330 |
Why?
|
| Cell Adhesion | 1 | 2010 | 426 | 0.330 |
Why?
|
| Reproducibility of Results | 4 | 2016 | 2770 | 0.300 |
Why?
|
| Fuzzy Logic | 3 | 2019 | 15 | 0.300 |
Why?
|
| Stress, Psychological | 2 | 2021 | 322 | 0.300 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1534 | 0.280 |
Why?
|
| Female | 13 | 2021 | 46656 | 0.280 |
Why?
|
| Expert Systems | 2 | 2004 | 18 | 0.260 |
Why?
|
| Postprandial Period | 2 | 2018 | 47 | 0.250 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2024 | 38 | 0.240 |
Why?
|
| Consensus | 2 | 2024 | 369 | 0.230 |
Why?
|
| Materials Testing | 2 | 2014 | 93 | 0.230 |
Why?
|
| Insulin, Regular, Human | 1 | 2023 | 6 | 0.230 |
Why?
|
| Bone and Bones | 2 | 2014 | 271 | 0.210 |
Why?
|
| Treatment Outcome | 5 | 2018 | 8313 | 0.200 |
Why?
|
| Stochastic Processes | 1 | 2002 | 77 | 0.200 |
Why?
|
| Heart Rate | 3 | 2019 | 497 | 0.190 |
Why?
|
| Diabetes Mellitus | 2 | 2024 | 743 | 0.190 |
Why?
|
| Animals | 8 | 2020 | 27553 | 0.180 |
Why?
|
| Glucose | 2 | 2022 | 628 | 0.180 |
Why?
|
| Immobilized Proteins | 1 | 2019 | 14 | 0.170 |
Why?
|
| Energy Metabolism | 3 | 2018 | 282 | 0.170 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 69 | 0.170 |
Why?
|
| Electrocardiography | 1 | 2002 | 497 | 0.160 |
Why?
|
| Sensitivity and Specificity | 4 | 2016 | 2019 | 0.160 |
Why?
|
| Proteolysis | 1 | 2019 | 114 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2002 | 332 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 124 | 0.160 |
Why?
|
| Infusion Pumps | 1 | 2018 | 25 | 0.160 |
Why?
|
| Resistance Training | 1 | 2018 | 13 | 0.160 |
Why?
|
| Time Factors | 4 | 2015 | 5364 | 0.160 |
Why?
|
| Oligopeptides | 1 | 2019 | 188 | 0.160 |
Why?
|
| Anxiety | 1 | 2020 | 311 | 0.150 |
Why?
|
| Basement Membrane | 1 | 2018 | 55 | 0.150 |
Why?
|
| Osteogenesis | 2 | 2020 | 258 | 0.140 |
Why?
|
| Regeneration | 1 | 2018 | 151 | 0.140 |
Why?
|
| Endothelial Cells | 2 | 2020 | 464 | 0.140 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 8 | 0.130 |
Why?
|
| Bioartificial Organs | 1 | 2015 | 2 | 0.130 |
Why?
|
| Computer-Aided Design | 1 | 2015 | 17 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2017 | 232 | 0.130 |
Why?
|
| Actigraphy | 1 | 2015 | 59 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2015 | 29 | 0.120 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 160 | 0.120 |
Why?
|
| Microspheres | 1 | 2015 | 108 | 0.120 |
Why?
|
| Exercise Test | 1 | 2015 | 167 | 0.120 |
Why?
|
| Prosthesis Design | 1 | 2015 | 300 | 0.120 |
Why?
|
| Child | 3 | 2015 | 7257 | 0.120 |
Why?
|
| Systems Integration | 1 | 2014 | 36 | 0.110 |
Why?
|
| Man-Machine Systems | 1 | 2014 | 10 | 0.110 |
Why?
|
| Printing, Three-Dimensional | 1 | 2014 | 45 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 48 | 0.110 |
Why?
|
| Penicillins | 2 | 2004 | 20 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 196 | 0.100 |
Why?
|
| Kinetics | 1 | 2015 | 1535 | 0.100 |
Why?
|
| Software Design | 2 | 2002 | 17 | 0.100 |
Why?
|
| Biomarkers | 2 | 2015 | 1780 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 405 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1871 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2010 | 331 | 0.090 |
Why?
|
| Cross-Linking Reagents | 1 | 2010 | 88 | 0.090 |
Why?
|
| Ligands | 1 | 2010 | 447 | 0.080 |
Why?
|
| Middle Aged | 2 | 2021 | 26195 | 0.080 |
Why?
|
| Linear Models | 1 | 2009 | 422 | 0.070 |
Why?
|
| Observer Variation | 1 | 2009 | 614 | 0.070 |
Why?
|
| Cross-Over Studies | 2 | 2019 | 388 | 0.070 |
Why?
|
| Peptides | 1 | 2010 | 649 | 0.070 |
Why?
|
| Bioreactors | 2 | 2004 | 11 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2018 | 9259 | 0.060 |
Why?
|
| Mice | 1 | 2018 | 11869 | 0.060 |
Why?
|
| Vinyl Compounds | 1 | 2002 | 7 | 0.050 |
Why?
|
| Transducers | 1 | 2002 | 42 | 0.050 |
Why?
|
| Quality Control | 1 | 2002 | 117 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2002 | 73 | 0.050 |
Why?
|
| Computer Graphics | 1 | 2002 | 100 | 0.050 |
Why?
|
| Fungi | 1 | 2002 | 66 | 0.050 |
Why?
|
| Polymers | 1 | 2002 | 196 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2002 | 187 | 0.050 |
Why?
|
| Bone Regeneration | 1 | 2020 | 62 | 0.040 |
Why?
|
| Pattern Recognition, Automated | 1 | 2002 | 221 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 37 | 0.040 |
Why?
|
| High-Intensity Interval Training | 1 | 2019 | 2 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 371 | 0.040 |
Why?
|
| Calorimetry, Indirect | 1 | 2018 | 14 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 245 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2002 | 870 | 0.040 |
Why?
|
| Suspensions | 1 | 2017 | 6 | 0.040 |
Why?
|
| Accelerometry | 1 | 2018 | 40 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2017 | 38 | 0.040 |
Why?
|
| Ontario | 1 | 2017 | 51 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 152 | 0.030 |
Why?
|
| Circadian Rhythm | 2 | 2010 | 303 | 0.030 |
Why?
|
| Automation | 1 | 2017 | 112 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2017 | 245 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2064 | 0.030 |
Why?
|
| Glucagon | 1 | 2015 | 111 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2015 | 72 | 0.030 |
Why?
|
| Polymethyl Methacrylate | 1 | 2015 | 13 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 872 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2015 | 197 | 0.030 |
Why?
|
| Polypropylenes | 1 | 2014 | 23 | 0.030 |
Why?
|
| Fumarates | 1 | 2014 | 19 | 0.030 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 46 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 91 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1706 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2013 | 48 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 458 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1237 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1136 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 602 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 63 | 0.020 |
Why?
|
| Monitoring, Ambulatory | 1 | 2010 | 32 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 94 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 4049 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 662 | 0.020 |
Why?
|
| United States | 1 | 2017 | 7118 | 0.010 |
Why?
|
| Biotechnology | 1 | 2002 | 28 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 147 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 3800 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 745 | 0.010 |
Why?
|